|
|
Volumn 22, Issue 15, 2001, Pages 1307-1310
|
|
The HOPE study: Comparison with other trials of secondary prevention
|
|
Author keywords
ACE inhibition in heart failure; HOPE study; Prevention; Statin trials; Treatment effect
|
|
Indexed keywords
ENALAPRIL;
RAMIPRIL;
SIMVASTATIN;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HEART INFARCTION;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTICHOLESTEREMIC AGENTS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MIDDLE AGED;
RAMIPRIL;
RISK;
|
|
EID: 0034910815
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.2000.2540 Document Type: Review |
|
Times cited : (23)
|
|
References (14)
|
